DEA, administrative law judge

DEA Judge Notifies Agency Head About Marijuana Rescheduling Hearing Cancelation Following Appeal Order
A Drug Enforcement Administration (DEA) judge has advised the head of the agency that the ball is back in her court with respect to the Biden administration’s marijuana rescheduling proposal, providing notice of a request for leave to file appeal that he granted this week in the hearing proceedings.
DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week
A DEA judge cancelled a hearing to consider a proposal to reclassify marijuana amid allegations that officials at the agency improperly conferred with witnesses.
DEA judge postpones cannabis rescheduling hearings, Marijuana Moment reports
DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after
Why Delaying DEA’s Biased Marijuana Rescheduling Hearing Is Good For The Cannabis Industry (Op-Ed)
Had we not intervened, the hearing would have gone ahead with DEA openly tipping the scales against rescheduling.” By Michael DeGiglio, Village Farms & Robert Head, Hemp for Victory As the leaders of Village Farms and Hemp for Victory,
Judge postpones DEA hearing on proposed rescheduling of marijuana
A last-minute Biden administration effort to loosen restrictions on marijuana by rescheduling, or reclassifying it, as a less dangerous drug has come up short. An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week,
DEA marijuana rescheduling hearing cancelled following legal challenge
A Drug Enforcement Agency hearing that was scheduled for Jan. 21 to discuss the Biden Administration's plans to reschedule marijuana has been cancelled due to a legal challenge from those who want the rescheduling to go through.
Justice Department Says Marijuana Rescheduling Case Should Be Paused In Federal Court After DEA Cancels Hearings
The Justice Department is telling a federal court that it should pause a lawsuit challenging the Drug Enforcement Administration’s (DEA) marijuana rescheduling process after the agency’s own judge cancelled upcoming administrative hearings that were set to start next week.
DEA, police imposters from Texas posed in disguises, then tried to rip off major marijuana grow in southern Oregon
Gammage, Lopez and the four others had left San Antonio on Feb. 22, 2022, and arrived in southern Oregon five days later, ...
Hosted on MSN2d
DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances
Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain ...
Central Texas man who unknowingly sold drugs to DEA sentenced
A Central Texas man received a 14-year prison sentence related to the distribution of fentanyl and other illegal controlled substances.
Retired head of Chicago DEA on shortlist to lead national agency under Trump administration
The former top dog at the DEA in Chicago told the ABC7 I-Team he is being courted to come back and lead the agency under ...
Fierce Healthcare4d
DEA proposes long-awaited special registration for telehealth prescribing, with heightened scrutiny for virtual platforms
The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special ...
DEA Ends Airport Gate Searches After Years of Documented Abuses of Civil Asset Forfeiture
The Drug Enforcement Administration (DEA) is ending searches of passengers at airports and other mass transit hubs after ...
DEA: Anti-fentanyl campaigns in New Mexico are working but more work is needed
Israeli Prime Minister Benjamin Netanyahu is tapping the brakes on claims of success by President Biden, President-elect ...
Modern Healthcare4d
Biden's DEA issues remote prescribing proposal
The Drug Enforcement Administration proposed a special registration process for remote prescribing of controlled substances ...
DEA, HHS finalize rule allowing telehealth drug treatment
Rule will make permanent the temporary waivers easing access to buprenorphine via telehealth that began during the COVID-19 ...